Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AGfiledCriticalSchering AG
Priority to ES0244889ApriorityCriticalpatent/ES244889A1/en
Publication of ES244889A1publicationCriticalpatent/ES244889A1/en
Process for obtaining new water-soluble steroidal combinations of hydrocortisone, characterized in that hydrocortisone is converted into physiologically usable salts, especially the sodium salt of its 21-hemisulfate, especially by actuation of the pyridine-sulfur trioxide adduct. (Machine-translation by Google Translate, not legally binding)
ES0244889A1958-10-251958-10-25Procedure for the obtaining of new monoazoic dyes (Machine-translation by Google Translate, not legally binding)
ExpiredES244889A1
(en)
Procedure for the preparation of new aqueous solutions of adrenocrome monosemicarbazone. (Machine-translation by Google Translate, not legally binding)